[HTML][HTML] The first 12 months of COVID-19: a timeline of immunological insights
Since the initial reports of a cluster of pneumonia cases of unidentified origin in Wuhan,
China, in December 2019, the novel coronavirus that causes this disease—severe acute …
China, in December 2019, the novel coronavirus that causes this disease—severe acute …
[HTML][HTML] SARS-CoV-2 in wastewater: State of the knowledge and research needs
The ongoing global pandemic of coronavirus disease 2019 (COVID-19) caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a Public Health …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a Public Health …
Smoking is associated with COVID-19 progression: a meta-analysis
R Patanavanich, SA Glantz - Nicotine and tobacco research, 2020 - academic.oup.com
Introduction Smoking depresses pulmonary immune function and is a risk factor contracting
other infectious diseases and more serious outcomes among people who become infected …
other infectious diseases and more serious outcomes among people who become infected …
The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?
Objectives To provide an overview of the three major deadly coronaviruses and identify
areas for improvement of future preparedness plans, as well as provide a critical …
areas for improvement of future preparedness plans, as well as provide a critical …
The effect of smoking on COVID‐19 severity: A systematic review and meta‐analysis
RK Reddy, WN Charles, A Sklavounos… - Journal of medical …, 2021 - Wiley Online Library
Various comorbidities represent risk factors for severe coronavirus disease 2019 (COVID‐
19). The impact of smoking on COVID‐19 severity has been previously reported in several …
19). The impact of smoking on COVID‐19 severity has been previously reported in several …
[HTML][HTML] COVID-19 and smoking: A systematic review of the evidence
CI Vardavas, K Nikitara - Tobacco induced diseases, 2020 - ncbi.nlm.nih.gov
COVID-19 is a coronavirus outbreak that initially appeared in Wuhan, Hubei Province,
China, in December 2019, but it has already evolved into a pandemic spreading rapidly …
China, in December 2019, but it has already evolved into a pandemic spreading rapidly …
[HTML][HTML] Insight into 2019 novel coronavirus—An updated interim review and lessons from SARS-CoV and MERS-CoV
M Xie, Q Chen - International Journal of Infectious Diseases, 2020 - Elsevier
Background The rapid spread of the coronavirus disease 2019 (COVID-19), caused by a
zoonotic beta-coronavirus entitled 2019 novel coronavirus (2019-nCoV), has become a …
zoonotic beta-coronavirus entitled 2019 novel coronavirus (2019-nCoV), has become a …
COVID-19: epidemiology, evolution, and cross-disciplinary perspectives
The recent outbreak of COVID-19 in Wuhan turned into a public health emergency of
international concern. With no antiviral drugs nor vaccines, and the presence of carriers …
international concern. With no antiviral drugs nor vaccines, and the presence of carriers …
Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children
P Zimmermann, N Curtis - The Pediatric infectious disease journal, 2020 - journals.lww.com
Coronaviruses (CoVs) are a large family of enveloped, single-stranded, zoonotic RNA
viruses. Four CoVs commonly circulate among humans: HCoV2-229E,-HKU1,-NL63 and …
viruses. Four CoVs commonly circulate among humans: HCoV2-229E,-HKU1,-NL63 and …
Quarantine alone or in combination with other public health measures to control COVID‐19: a rapid review
B Nussbaumer-Streit, V Mayr… - Cochrane Database …, 2020 - cochranelibrary.com
Background Coronavirus disease 2019 (COVID‐19) is a rapidly emerging disease classified
as a pandemic by the World Health Organization (WHO). To support the WHO with their …
as a pandemic by the World Health Organization (WHO). To support the WHO with their …